Page last updated: 2024-09-03

4-(benzodioxan-5-yl)-1-(indan-2-yl)piperazine and fenfluramine

4-(benzodioxan-5-yl)-1-(indan-2-yl)piperazine has been researched along with fenfluramine in 1 studies

Compound Research Comparison

Studies
(4-(benzodioxan-5-yl)-1-(indan-2-yl)piperazine)
Trials
(4-(benzodioxan-5-yl)-1-(indan-2-yl)piperazine)
Recent Studies (post-2010)
(4-(benzodioxan-5-yl)-1-(indan-2-yl)piperazine)
Studies
(fenfluramine)
Trials
(fenfluramine)
Recent Studies (post-2010) (fenfluramine)
42093,112478222

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cremers, TI; de Boer, SF; Koolhaas, JM; Lieuwes, N; van der Vegt, BJ1

Other Studies

1 other study(ies) available for 4-(benzodioxan-5-yl)-1-(indan-2-yl)piperazine and fenfluramine

ArticleYear
Cerebrospinal fluid monoamine and metabolite concentrations and aggression in rats.
    Hormones and behavior, 2003, Volume: 44, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; 5,7-Dihydroxytryptamine; Aggression; Animals; Biogenic Monoamines; Chromatography, High Pressure Liquid; Dopamine; Fenfluramine; Hydroxyindoleacetic Acid; Male; Norepinephrine; Piperazines; Pyridines; Rats; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists

2003